- Home
- Publications
- Publication Search
- Publication Details
Title
The interferon-alpha revival in CML
Authors
Keywords
Chronic myeloid leukemia, Interferon-alpha, Imatinib, Tyrosine kinase inhibitor, Myeloproliferative neoplasms
Journal
ANNALS OF HEMATOLOGY
Volume 94, Issue S2, Pages 195-207
Publisher
Springer Nature
Online
2015-03-26
DOI
10.1007/s00277-015-2326-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons
- (2014) Eric M. Pietras et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib
- (2014) L. Legros et al. LEUKEMIA RESEARCH
- Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era
- (2013) Michele Malagola et al. AMERICAN JOURNAL OF HEMATOLOGY
- JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN
- (2013) S. Hasan et al. BLOOD
- Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia
- (2013) Hyacinthe Johnson-Ansah et al. CANCER
- Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche
- (2013) Koen Schepers et al. Cell Stem Cell
- Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV
- (2013) Rüdiger Hehlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Interferons as Inducers of Apoptosis in Malignant Cells
- (2013) Kevin P. Kotredes et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Biological Rationale and Clinical Use of Interferon in the Classical BCR-ABL-Negative Myeloproliferative Neoplasms
- (2013) Brady L. Stein et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Hope and Fear for Interferon: The Receptor-Centric Outlook on the Future of Interferon Therapy
- (2013) Serge Y. Fuchs JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Arteriolar niches maintain haematopoietic stem cell quiescence
- (2013) Yuya Kunisaki et al. NATURE
- Interferon alpha for Treatment of Chronic Myeloid Leukemia
- (2012) Bengt Simonsson et al. CURRENT DRUG TARGETS
- Combination of pegylated IFN- 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
- (2011) B. Simonsson et al. BLOOD
- The renaissance of interferon therapy for the treatment of myeloid malignancies
- (2011) J.-J. Kiladjian et al. BLOOD
- Treatment with Interferon alpha prior to discontinuation of Imatinib in patients with chronic myeloid leukemia
- (2011) Izhar Hardan et al. CYTOKINE
- Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia
- (2011) Rüdiger Hehlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
- (2011) Hans Carl Hasselbalch Expert Review of Hematology
- Interferon-α as angiogenesis inhibitor: Learning from tumor models
- (2010) Stefano Indraccolo AUTOIMMUNITY
- Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity
- (2010) Paola Rizza et al. AUTOIMMUNITY
- Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia
- (2010) Jorge Cortes et al. CANCER
- Interferon alpha-2b as therapy for patients with Ph‘-positive chronic myelogenous leukemia
- (2010) Giuliana Alimena et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8+ T cells
- (2010) Sandra Hervas-Stubbs et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interferon-α targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway
- (2010) Min Lu et al. EXPERIMENTAL HEMATOLOGY
- The response to imatinib and interferon- is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
- (2010) F. Palandri et al. HAEMATOLOGICA
- Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia
- (2010) Andreas Burchert et al. JOURNAL OF CLINICAL ONCOLOGY
- Type I interferon: friend or foe?
- (2010) Giorgio Trinchieri JOURNAL OF EXPERIMENTAL MEDICINE
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
- (2010) Claude Preudhomme et al. NEW ENGLAND JOURNAL OF MEDICINE
- PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal
- (2010) Shreya Kanodia et al. PLoS One
- Early and Sustained Virological Response in Non-Responders with Chronic Hepatitis C
- (2009) Gaetano Scotto et al. DRUGS
- Pegylated interferon 2a plus ribavirin versus pegylated interferon 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
- (2009) J. Berenguer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Role of Schlafen 2 (SLFN2) in the Generation of Interferon α-induced Growth Inhibitory Responses
- (2009) Efstratios Katsoulidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
- (2009) A Hochhaus et al. LEUKEMIA
- IFNα activates dormant haematopoietic stem cells in vivo
- (2009) Marieke A. G. Essers et al. NATURE
- Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon–dependent exhaustion
- (2009) Taku Sato et al. NATURE MEDICINE
- Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses
- (2009) S. Joshi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interferon- 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes
- (2008) A. Yamane et al. BLOOD
- Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon- : 5-year outcome
- (2008) F. Palandri et al. HAEMATOLOGICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started